Advertisement

Picture [iito] Life Science Business Portals Media Data 2022 2 650x100px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Europe and Israel or involving organisations from these countries.

Total search results: 8059 | Ordered by Date (descending)
1 2 3 ... 79 80 81  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
SPT Labtech–EQT: investment, 202206– acquisition £650m of SPT Labtech by EQT IX Fund from Battery Ventures 2022-06-22
Abound Bio–Galapagos: investment, 202206 acquisition $14m in cash of AboundBio by Galapagos 2022-06-21
CellPoint–Galapagos: investment, 202206 acquisition in cash €125m upfront + €100m milestones of CellPoint by Galapagos 2022-06-21
CH-Bioforce–EU (govt): grant, 202206– EIC Accelerator programme grant up to €15m to advance biomass processing plant 2022-06-21
ProtonDx–SciTribe: public relations, 202206 service existent by SciTribe 2022-06-21
Elypta–Bonnier: investment, 202206 financing round Series A totalling $21m incl lead investor Bonnier Ventures 2022-06-20
Elypta–Chalmers Univ: investment, 202206 financing round Series A totalling $21m incl existing + co-investor Chalmers Ventures 2022-06-20
Elypta–Hillclimber: investment, 202206 financing round Series A totalling $21m incl existing + co-investor Hillclimber 2022-06-20
Elypta–Nina Capital: investment, 202206 financing round Series A totalling $21m incl existing + co-investor Nina Capital 2022-06-20
Elypta–Norrsken Foundation: investment, 202206 financing round Series A totalling $21m incl existing + co-investor Norrsken VC 2022-06-20
Elypta–SEVERAL: investment, 202206 financing round Series A $21m led by Bonnier Ventures 2022-06-20
Elypta–Sweden (govt): investment, 202206 financing round Series A totalling $21m incl existing + co-investor Industrifonden 2022-06-20
Elypta–Wallenberg: investment, 202206 financing round Series A totalling $21m incl existing + co-investor Navigare Ventures 2022-06-20
Kranus Health–A Round Capital: investment, 202206 financing round Series A totalling >$6.5m incl existing + co-investor A Round Capital 2022-06-20
Kranus Health–High-Tech Gründerfonds: investment, 202206 financing round Series A totalling >$6.5m incl existing + co-investor HTGF 2022-06-20
Kranus Health–Karista: investment, 202206 financing round Series A totalling >$6.5m incl lead investor Karista 2022-06-20
Kranus Health–Peak Pride: investment, 202206 financing round Series A totalling >$6.5m incl co-investor Peak Pride 2022-06-20
Kranus Health–PERSON: investment, 202206 financing round Series A totalling >$6.5m incl co-investor Ehsan Khaljani 2022-06-20
Kranus Health–PERSON: investment, 202206 financing round Series A totalling >$6.5m incl co-investor Florian Brand 2022-06-20
Kranus Health–Saarbruecker21: investment, 202206 financing round Series A totalling >$6.5m incl co-investor business angel group Saarbruecker21 2022-06-20
Kranus Health–SEVERAL: investment, 202206 financing round Series A >$6.5m led by Karista 2022-06-20
High-Tech Gründerfonds–SEVERAL: investment, 202206 1st closing of HTGF IV at more than €400m incl BMWK + KfW Capital 2022-06-14
JnJ–Evotec: drug discovery services, 202206– collab discover novel mode of action drugs using TargetAlloMod platforms for Janssen Pharmaceutica 2022-06-14
Spirea–ACF Investors: investment, 202206 financing round totalling £2.4m incl co-investor ACF Investors 2022-06-14
Spirea–Cambridge Angels: investment, 202206 financing round totalling £2.4m incl co-investor Cambridge Angels 2022-06-14
Spirea–Meltwind: investment, 202206 financing round totalling £2.4m incl existing + co-lead investor Jonathan Milner 2022-06-14
Spirea–o2h: investment, 202206 financing round totalling £2.4m incl existing + co-investor o2h Ventures 2022-06-14
Spirea–R42 Group: investment, 202206 financing round totalling £2.4m incl co-investor R42 Group 2022-06-14
Spirea–SEVERAL: investment, 202206 financing round £2.4m led by Jonathan Milner + Cambridge Enterprise 2022-06-14
Spirea–SyndicateRoom: investment, 202206 financing round totalling £2.4m incl existing + co-investor Syndicate Room 2022-06-14
Spirea–Univ Cambridge: investment, 202206 financing round totalling £2.4m incl existing + co-lead investor Cambridge Enterprise 2022-06-14
ImCheck Therapeutics–SEVERAL: investment, 202206 financing round Series C €80m co-led by new investors Earlybird + Andera Partners 2022-06-13
Charm Therapeutics–Axial: investment, 202206 financing round Series A totalling $50m incl co-investor Axial 2022-06-09
Charm Therapeutics–Braavos Investment Advisers: investment, 202206 financing round Series A totalling $50m incl co-investor Braavos 2022-06-09
Charm Therapeutics–Consilium: public relations, 202206 service existent by Consilium Strategic Communications 2022-06-09
Charm Therapeutics–F-Prime: investment, 202206 financing round Series A totalling $50m incl co-lead investor F-Prime Capital 2022-06-09
Charm Therapeutics–General Catalyst: investment, 202206 financing round Series A totalling $50m incl co-investor General Catalyst 2022-06-09
Charm Therapeutics–Khosla Ventures: investment, 202206 financing round Series A totalling $50m incl co-investor Khosla Ventures 2022-06-09
Charm Therapeutics–OrbiMed: investment, 202206 financing round Series A totalling $50m incl co-lead investor OrbiMed 2022-06-09
Charm Therapeutics–SEVERAL: investment, 202206 financing round Series A $50m co-led by F-Prime Capital + OrbiMed 2022-06-09
Forbion–SEVERAL: investment, 202206 first close €470m of Forbion Growth Opportunities Fund II with target size of €600m hard cap 2022-06-09
Peptone–Bessemer Venture: investment, 202206 financing round Series A totalling $40m incl co-lead investor Bessemer Venture Partners 2022-06-09
Peptone–F-Prime: investment, 202206 financing round Series A totalling $40m incl co-lead investor F-Prime Capital 2022-06-09
Peptone–Hoxton Ventures: investment, 202206 financing round Series A totalling $40m incl existing + co-investor Hoxton Ventures 2022-06-09
Peptone–Novartis: investment, 202206 financing round Series A totalling $40m incl existing + co-investor dRX Capital 2022-06-09
Peptone–Nvidia: AI-based drug discovery, 202206 collab incl use of Nvidia DGX A100 supercomputer to run Peptone’s algorithmic engine 2022-06-09
Peptone–SEVERAL: investment, 202206 financing round Series A $40m led by F-Prime + Bessemer Venture Partners 2022-06-09
Peptone–Walden Catalyst: investment, 202206 financing round Series A totalling $40m incl co-investor Walden Catalyst Vemtures 2022-06-09
Relation Therapeutics–SEVERAL: investment, 202206 seed financing round $25m co-led by DCVC + Magentic Ventures 2022-06-09
Ariceum Therapeutics–Bellevue: investment, 202206 financing round Series A totalling €25m incl co-investor Pureos Bioventures 2022-06-08
Ariceum Therapeutics–EQT: investment, 202206 financing round Series A totalling €25m incl co-founding + co-lead investor EQT Life Sciences 2022-06-08
Ariceum Therapeutics–Odlander Fredrikson: investment, 202206 financing round Series A totalling €25m incl co-founding + co-lead investor HealthCap 2022-06-08
Ariceum Therapeutics–Optimum Strategic Communications: public relations, 202206 service existent by Optimum 2022-06-08
Ariceum Therapeutics–SEVERAL: investment, 202206 financing round Series A €25m co-led by HealthCap + EQT Life Sciences 2022-06-08
BioVersys–SEVERAL: investment, 202206 financing round Series C first closing CHF24.2m from existing + new investors 2022-06-08
Frame Cancer Therapeutics–CureVac: investment, 202206 acquisition in shares €32m with €16m upfront + €16m milestones 2022-06-08
Synklino–Denmark (govt): investment, 202206 financing round Series A totallling €29.8m incl existing + co-investor Vaekstfonden 2022-06-08
Synklino–Eir Ventures: investment, 202206 financing round Series A totallling €29.8m incl existing + co-investor Eor Vemtures 2022-06-08
Synklino–Maj Invest: investment, 202206 financing round Series A totallling €29.8m incl new + co-investor Maj Invest 2022-06-08
Synklino–Optimum Strategic Communications: public relations, 202206 service existent by Optimum 2022-06-08
Synklino–PKA: investment, 202206 financing round Series A totallling €29.8m incl new + lead investor PKA Pension Fund 2022-06-08
Synklino–SEVERAL: investment, 202206 financing round Series A €29.8m (DKK222m) led by PKA Pension Fund 2022-06-08
CimCure–Intravacc: cancer vaccine, 202206 collab existent developm + production of lead compound of CimCure 2022-06-07
CimCure–PERSON: investment, 202206 seed financing round totalling €5m incl co-investor investment vehicle of Tom Würdinger 2022-06-07
CimCure–Positron Ventures: investment, 202206 seed financing round totalling €5m incl lead investor Positron Ventures 2022-06-07
CimCure–SEVERAL: investment, 202206 seed financing round €5m led by Positron Ventures 2022-06-07
ImmunOs Therapeutics–BioMedPartners: investment, 202206 financing round Series B totalling $74m incl existing + co-investor BioMedPartners 2022-06-07
ImmunOs Therapeutics–Fiscus Financial: investment, 202206 financing round Series B totalling $74m incl new + co-investor Fiscus Financial 2022-06-07
ImmunOs Therapeutics–Gimv: investment, 202206 financing round Series B totalling $74m incl new + co-lead investor Gimv 2022-06-07
ImmunOs Therapeutics–GL Capital: investment, 202206 financing round Series B totalling $74m incl new + co-investor GL Capital 2022-06-07
ImmunOs Therapeutics–Lightspeed Venture Partners: investment, 202206 financing round Series B totalling $74m incl new + co-lead investor Lightspeed VP 2022-06-07
ImmunOs Therapeutics–Mission BioCapital: investment, 202206 financing round Series B totalling $74m incl new + co-investor Mission BioCapital 2022-06-07
ImmunOs Therapeutics–Peak6 Strategic Capital: investment, 202206 financing round Series B totalling $74m incl new + co-investor Peak6 2022-06-07
ImmunOs Therapeutics–Pfizer: investment, 202206 financing round Series B totalling $74m incl existing + co-investor Pfizer Ventures 2022-06-07
ImmunOs Therapeutics–Samsara BioCapital: investment, 202206 financing round Series B totalling $74m incl new + co-lead investor Samsara BioCapital 2022-06-07
ImmunOs Therapeutics–Schroders: investment, 202206 financing round Series B totalling $74m incl existing + co-investor Schroder Adveq 2022-06-07
ImmunOs Therapeutics–SEVERAL: investment, 202206 financing round Series B $74m led by Samsara BioCapital + Lightspeed VP + Gimv 2022-06-07
Vizgen–SEVERAL: investment, 202206 financing round Series C $85.2m co-led by Blue Water Life Science + ARCH Venture Partners 2022-06-03
Vizgen–Sofina: investment, 202206 financing round Series C totalling $85.2m incl co-investor Sofina 2022-06-03
BMS–Immatics: cancer immunotherapy, 202201– collab strategic alliance expansion $60m upfront + $700 milestones per programme using ACTallo platform 2022-06-02
Merck (DE)–Proxygen: molecular glue degraders, 202206– strategic multi-year collab + license agreem up to €495m plus royalties 2022-06-02
Transition Bio–SEVERAL: investment, 202206 financing round Series A $50m led by Northpond Ventures 2022-06-02
Weezion–Mérieux: in-vitro diagnostics, 202206– collab technical assistance from bioMérieux to develop MS-based sepsis IVD 2022-06-01
Weezion–Mérieux: investment, 202206 investment €2m from bioMérieux for a 4.26% share accompanied by technical assistance 2022-06-01
Affinivax–GSK: investment, 202205– acquisition 100% for $2.1b upfront + $1.2b milestones by GSK ANNOUNCED 2022-05-31
Firmenich–DSM: investment, 202205– merger with former DMS owners holding 65.5% + Firmenich owners receiving 34.5% plus €3.5b in cash ANNOUNCED 2022-05-31
Minoryx–Columbus Venture Partners: investment, 202205 financing round Series C incl co-lead investor Columbus Venture Partners 2022-05-31
Minoryx–Fund+: investment, 202205 financing round Series C incl existing + co-investor Fund+ 2022-05-31
Minoryx–la Caixa: investment, 202205 financing round Series C incl existing + co-lead investor Caixa Capital Risc 2022-05-31
Minoryx–SEVERAL: credit, 202205 complementary bank debt to Series C financing round (both tog totalling €51m) 2022-05-31
Minoryx–SEVERAL: investment, 202205 financing round Series C (incl complementary bank totalling €51m) led by Columbus VP + Caixa Capital Risc 2022-05-31
Minoryx–Spain (govt): investment, 202205 financing round Series C incl new + co-investor CDTI Innvierte 2022-05-31
Minoryx–Ysios Capital: investment, 202205 financing round Series C incl existing + co-investor Ysios Capital 2022-05-31
Repertoire Genesis–Eurofins: investment, 202205 acquisition of majority stake by Eurofins Scientific 2022-05-31
Transine Therapeutics–Epidarex Capital: investment, 202205 seed financing round expansion totalling £4.6m incl new + lead investor Epidarex 2022-05-31
Transine Therapeutics–SEVERAL: investment, 202205 seed financing round expansion £4.6m led by Epidarex bringing total seed round to £13.7m 2022-05-31
Transine Therapeutics–SV Health Investors: investment, 202205 seed financing round expansion totalling £4.6m incl existing + co-investor DDF 2022-05-31
Ultima Genomics–aMoon: investment, 202205 emerges from stealth with $600m incl investor aMoon 2022-05-31
Ultima Genomics–PERSON: investment, 202205 emerges from stealth with $600m incl investor Marius Nacht 2022-05-31
Ultima Genomics–SEVERAL: investment, 202205 emerges from stealth with $600m raised from leading life science investors 2022-05-31
1 2 3 ... 79 80 81  next pagenext page



Advertisement

Picture [iito] No Tracking 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top